Literature DB >> 22494864

Moderate dietary weight loss reduces myocardial steatosis in obese and overweight women.

Wolfgang Utz1, Stefan Engeli, Sven Haufe, Petra Kast, Jana Böhnke, Verena Haas, Mario Hermsdorf, Susanne Wiesner, Martin Pofahl, Julius Traber, Friedrich C Luft, Michael Boschmann, Jens Jordan, Jeanette Schulz-Menger.   

Abstract

BACKGROUND: Excessive myocardial triglyceride (MTG) content in obesity and type 2 diabetes is associated with impaired cardiac function. Previous studies suggest that MTG could be mobilized through lifestyle interventions. We assessed influences of moderate dietary weight loss in non diabetic obese and overweight women on MTG content and cardiac function.
METHODS: We selected a subgroup of 38 women from the B-SMART study population. The B-SMART study compared weight loss and associated metabolic and cardiovascular markers with reduced-carbohydrate and reduced-fat hypocaloric diets. Selected subjects had completed a cardiac magnetic resonance (MR) scan including imaging and proton spectroscopy to assess cardiac structure and function as well as MTG content.
RESULTS: An average weight reduction of 5.4 ± 4.3 kg at six months was associated with a relative decrease of MTG of 25% (from 0.72 ± 0.29% at baseline to 0.54 ± 0.23% at follow-up, p<0.001). The response was similar with carbohydrate and fat restriction. Diastolic function expressed as ratio of peak filling rate in E- and A-Phase (PFRE/PFRA) was unchanged. Reductions of left atrial size (from 21.9 ± 4.0 cm(2) to 20.0 ± 3.7 cm(2), p=0.002), the normalized ratio of PFRE and early diastolic lengthening velocity PLV (from 8.2 ± 2.6 to 7.5 ± 2.5, p<0.001) and fat free mass (from 55.1 ± 6.9 kg to 52.7 ± 6.5 kg, p=0.007) reflected altered cardiac volume loading after diet, but did not correlate to MTG content.
CONCLUSIONS: Moderate dietary weight loss significantly reduced MTG content in women with uncomplicated overweight or obesity. Macronutrient composition of the diet did not significantly affect the extent of MTG reduction.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Magnetic resonance spectroscopy; Metabolism; Obesity

Mesh:

Substances:

Year:  2012        PMID: 22494864     DOI: 10.1016/j.ijcard.2012.03.104

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

1.  Impact of general and central adiposity on ventricular-arterial aging in women and men.

Authors:  Peter Wohlfahrt; Margaret M Redfield; Francisco Lopez-Jimenez; Vojtech Melenovsky; Garvan C Kane; Richard J Rodeheffer; Barry A Borlaug
Journal:  JACC Heart Fail       Date:  2014-09-03       Impact factor: 12.035

Review 2.  Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging.

Authors:  Arnold C T Ng; Victoria Delgado; Barry A Borlaug; Jeroen J Bax
Journal:  Nat Rev Cardiol       Date:  2020-11-13       Impact factor: 32.419

3.  Reversibility of myocardial metabolism and remodelling in morbidly obese patients 6 months after bariatric surgery.

Authors:  Jarna C Hannukainen; Riikka Lautamäki; Jussi Pärkkä; Marjatta Strandberg; Virva Saunavaara; Saija Hurme; Minna Soinio; Prince Dadson; Kirsi A Virtanen; Tove Grönroos; Sarita Forsback; Paulina Salminen; Patricia Iozzo; Pirjo Nuutila
Journal:  Diabetes Obes Metab       Date:  2018-01-17       Impact factor: 6.577

4.  Dietary normalization from a fat, fructose and cholesterol-rich diet to chow limits the amount of myocardial collagen in a Göttingen Minipig model of obesity.

Authors:  Laura Jul Andreasen; Simone Krog; Trine Pagh Ludvigsen; Ole Lerberg Nielsen; Jacob Eifer Møller; Berit Østergaard Christoffersen; Henrik Duelund Pedersen; Lisbeth Høier Olsen
Journal:  Nutr Metab (Lond)       Date:  2018-09-25       Impact factor: 4.169

5.  Exercise Training Adds Cardiometabolic Benefits of a Paleolithic Diet in Type 2 Diabetes Mellitus.

Authors:  Julia Otten; Jonas Andersson; Jens Ståhl; Andreas Stomby; Ahmed Saleh; Maria Waling; Mats Ryberg; Jon Hauksson; Michael Svensson; Bengt Johansson; Tommy Olsson
Journal:  J Am Heart Assoc       Date:  2019-01-22       Impact factor: 5.501

Review 6.  Diabetic cardiomyopathy: prevalence, determinants and potential treatments.

Authors:  Gaurav S Gulsin; Lavanya Athithan; Gerry P McCann
Journal:  Ther Adv Endocrinol Metab       Date:  2019-03-27       Impact factor: 3.565

Review 7.  Metabolic Profiling of the Diabetic Heart: Toward a Richer Picture.

Authors:  Alice P Sowton; Julian L Griffin; Andrew J Murray
Journal:  Front Physiol       Date:  2019-05-31       Impact factor: 4.566

8.  Effects of weight loss on myocardial energetics and diastolic function in obesity.

Authors:  O J Rider; J M Francis; D Tyler; J Byrne; K Clarke; S Neubauer
Journal:  Int J Cardiovasc Imaging       Date:  2012-12-27       Impact factor: 2.357

9.  The relative contribution of metabolic and structural abnormalities to diastolic dysfunction in obesity.

Authors:  J J Rayner; R Banerjee; C J Holloway; A J M Lewis; M A Peterzan; J M Francis; S Neubauer; O J Rider
Journal:  Int J Obes (Lond)       Date:  2017-10-04       Impact factor: 5.095

Review 10.  Cardiac Steatosis in HIV-A Marker or Mediator of Disease?

Authors:  Morgan Jacob; Cameron J Holloway
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.